Loading...
XTAI
4106
Market cap77mUSD
Jul 14, Last price  
22.40TWD
1D
-0.67%
1Q
3.94%
Jan 2017
-33.83%
IPO
106.45%
Name

Wellell Inc

Chart & Performance

D1W1MN
No data to show
P/E
19.62
P/S
0.95
EPS
1.14
Div Yield, %
3.57%
Shrs. gr., 5y
-0.81%
Rev. gr., 5y
3.23%
Revenues
2.39b
-9.84%
1,577,269,0001,661,216,0001,748,518,0001,845,771,0002,016,971,0002,263,357,0002,015,894,0001,990,275,0002,089,277,0002,105,748,0002,036,232,0002,004,025,0002,374,055,0002,663,723,0002,647,122,0002,386,654,000
Net income
115m
-24.27%
212,185,000180,681,000232,561,000196,220,000133,466,000178,414,000168,745,000122,504,000118,263,000108,413,00087,921,000104,588,000102,247,000161,404,000152,172,000115,239,000
CFO
213m
-53.20%
305,286,000191,310,000285,887,000254,359,000219,054,000248,329,000277,010,000218,586,000178,212,000118,990,000173,624,000279,321,00019,005,00082,145,000455,658,000213,234,000
Dividend
Jul 31, 20240.8 TWD/sh

Profile

Apex Medical Corp. provides medical solutions for healthcare professionals worldwide. The company offers wound management products, including Serene Air and Serene Elite, which are alternating pressure redistribution systems for patients with high to very high risk for pressure ulcers; ACS Turn, a lateral turning mattress for prevention of ventilator-associated pneumonia; Pro-care Optima, an alternating pressure redistribution system for patients with high to very high risk of pressure injuries; Pro-care turn, a bilateral turning air mattress for patients with medium to high risk of pressure injuries; Domus Auto, Domus 4, and Verso for patients with medium to high risk of pressure injury; Domus 3 for patients with medium risk of pressure injury; Domus 2s for patients with low to medium risk of pressure injury; Domus 1 for patients in low risk of pressure injury; Sedens 500 and Sedens 400, which are seat cushions; and Flexi-Air, a non-powered hybrid mattress. It also provides respiratory therapy products, such as nasal masks, full face masks, nasal pillows mask, portable suction unit, and compressor nebulizers; iCH Auto and XT Auto for automatic positive airway pressure; XT Prime, XT Sense, and XT Fit for continuous positive airway pressure; and medical equipment. Apex Medical Corp. was founded in 1990 and is headquartered in New Taipei City, Taiwan.
IPO date
Jan 02, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,386,654
-9.84%
2,647,122
-0.62%
2,663,723
12.20%
Cost of revenue
2,240,207
2,453,062
2,477,600
Unusual Expense (Income)
NOPBT
146,447
194,060
186,123
NOPBT Margin
6.14%
7.33%
6.99%
Operating Taxes
32,193
56,841
38,423
Tax Rate
21.98%
29.29%
20.64%
NOPAT
114,254
137,219
147,700
Net income
115,239
-24.27%
152,172
-5.72%
161,404
57.86%
Dividends
(80,729)
(85,775)
(55,501)
Dividend yield
3.33%
2.92%
1.86%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
186,527
223,386
322,338
Long-term debt
159,430
184,968
222,217
Deferred revenue
Other long-term liabilities
1,553
36,026
35,002
Net debt
(342,586)
(279,022)
80,110
Cash flow
Cash from operating activities
213,234
455,658
82,145
CAPEX
(56,909)
(28,826)
(47,992)
Cash from investing activities
(61,527)
(52,895)
(32,901)
Cash from financing activities
(152,986)
(200,381)
(145,833)
FCF
177,363
322,489
(32,057)
Balance
Cash
797,767
759,306
550,442
Long term investments
(109,224)
(71,930)
(85,997)
Excess cash
569,210
555,020
331,259
Stockholders' equity
1,605,962
1,431,391
1,892,263
Invested Capital
2,164,261
2,186,427
2,383,581
ROIC
5.25%
6.01%
6.41%
ROCE
5.34%
7.06%
6.86%
EV
Common stock shares outstanding
97,288
101,573
101,536
Price
24.90
-13.84%
28.90
-1.70%
29.40
0.00%
Market cap
2,422,459
-17.48%
2,935,460
-1.66%
2,985,158
0.21%
EV
2,085,523
2,661,327
3,071,562
EBITDA
241,658
287,823
279,434
EV/EBITDA
8.63
9.25
10.99
Interest
12,971
14,184
10,183
Interest/NOPBT
8.86%
7.31%
5.47%